The cGMP synthesis and PKG1 expression in murine lymphoid organs

Archivum Immunologiae et Therapiae Experimentalis

Volumn 50, Issue 4, 2002, Pages 289-294

  Kurowska, Ewa ^a   Kobiałka, Marcin ^a   Zioło, Ewa ^a   Strzadała, Leon ^a   Gorczyca, Wojciech A ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Cyclic nucleotides; Guanylyl cyclases; Lymphoid organs; Protein kinases; Signal transduction

Indexed keywords

CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ISOENZYME;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; LYMPHOID TISSUE; METABOLISM; MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; ISOENZYMES; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL;

EID: 1842869191     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. BANICK P. D., CHEN Q., XU Y. A. and THOM S. R. (1997): Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis. J. Cell Physiol., 172, 12-24.
2. BAUER H., JUNG T., TSIKAS D., STICHTENOTH D. O., FROLICH J. C. and NEUMANN C. (1997): Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology, 90, 205-211.
3. DIAMANTSTEIN T. and ULMER A. (1975): Regulation of DNA synthesis by guanosine-5'-diphosphate, cyclic guanosine-3', 5'-monophosphate, and cyclic adenosine-3', 5'-monophosphate in mouse lymphoid cells. Exp. Cell Res., 93, 309-314.
4. FAN X., WANG Y., LONDON M. R., EBER S. L., KRAUSE W. J., FREEMAN R. H. and FORTE R. L. (1997): Signaling pathways for guanylin and uroguanylin in the digestive, renal, central nervous, reproductive, and lymphoid systems. Endocrinology, 138, 4636-4648.
5. FISHER T. A., PALMETSHOFER A., GAMBARYAN S., BUTT E., JASSOY C., WALTER U., SOPPER S. and LOHMANN S. M. (2001): Activation of cGMP-dependent protein kinase Iβ inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells. J. Biol. Chem., 276, 5697-5974.
6. FORTE L. R., EBER S. L., FAN X., LONDON R. M., WANG Y., ROWLAND L. M., CHIN D. T., FREEMAN R. H. and KRAUSE W. J. (1999): Lymphoguanylin: cloning and characterization of a unique member of the guanylin peptide family. Endocrinology, 140, 1800-1806.
7. FRANCIS S. H. and CORBIN J. D. (1994): Progress in understanding the mechanism and function of cyclic GMP-dependent protein kinase. Adv. Pharmacol., 26, 115-169.
8. GENARO A. M., HORTELANO S., ALVAREZ A., MARTINEZ C. and BOSCA L. (1995): Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Invest., 95, 1884-1890.
9. + double-positive thymocytes. J. Immunol., 164, 1689-1694.
10. HARBRECHT B. G., WANG S. C., SIMMONS R. L. and BILLIAR T. R. (1995): Cyclic GMP and guanylate cyclase mediate lipopolysaccharide-induced Kupffer cell tumor necrosis factor-alpha synthesis. J. Leukoc. Biol., 57, 297-302.
11. + mononuclear blood cells. J. Mol. Med., 74, 629-635.
12. IVANOVA K., DAS P. K., VAN DEN WIJNGAARD R., LENZ W., KLOCKENBRING T., MALCHARZYK V., DRUMMER C. and GERZER R. (2001): Differential expression of functional guanylyl cyclase in melanocytes: absence of nitric-oxide-sensitive isoform in metastatic cells. J. Invest. Dermatol., 116, 409-416.
13. IZUMI T., SAITO Y., KISHIMOTO I., HARADA M., KUWAHARA K., HAMANAKA I., TAKAHASHI N., KAWAKAMI R., LI Y., TAKEMURA G., FUJIWARA H., GARBERS D. L., MOCHIZUKI S. and NAKAO K. (2001): Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-κB activation and alleviates myocardial ischemia/reperfusion injury. J. Clin. Invest., 108, 203-213.
14. JUTEL M., WATANABE T., KLUNKER S., AKDIS M., THOMET O. A., MALOLEPSZY J., ZAK-NEJMARK T., KOGA R., KOBAYASHI T., BLASER K. and AKDIS C. A. (2001): Histamine regulates T-cell and antibody response by differential expression of H1 and H2 receptors. Nature, 413, 420-425.
15. KALRA D., BAUMGARTEN G., DIBBS Z., SETA Y., SIVASUB-RAMANIAN N. and MANN D. L. (2000): Nitric oxide provokes tumor necrosis factor-α expression in adult feline myocardium through a cGMP-dependent pathway. Circulation, 102, 1302-1307.
16. KAMISATO S., UEMURA Y., TAKAMI N. and OKAMOTO K. (1997): Involvement of intracellular cyclic GMP and cyclic GMP-dependent protein kinase in alpha-elastin-induced macrophage chemotaxis. J. Biochem., 121, 862-867.
17. KIEMER A. K., HARTUNG T. and VOLLMAR A. M. (2000): cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J. Immunol., 165, 175-181.
18. KOBIAŁKA M. and GORCZYCA W. A. (2000): Particulate guanylyl cyclases: multiple mechanisms of activation. Acta Biochim. Pol.,49, 517-528.
19. KOBIAŁKA M., KARWACKA-KRUPIŃSKA K., ZIOŁO E., FASSLER R., STRZADAŁA L. and GORCZYCA W. A. (2000): Correlation of guanylyl cyclase activity with PKG1 expression during maturation of mouse T lymphocytes, Immunol. Lett., 73. 119.
20. KOSONEN O., KANKAANRANTA H., VUORINEN P. and MOILANEN E. (1997): Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives. Eur. J. Pharmacol., 337, 55-61.
21. KURIHARA M., KATAMINE S. and SAAVEDRA J. M. (1987): Atrial natriuretic peptide, ANP(99-126), receptors in rat thymocytes and spleen cells. Biochem. Biophys. Res. Commun., 145, 789-796.
22. LAWRENCE D. W. and PRYZWANSKY K. B. (2001): The vasodilator-stimulated phosphoprotein is regulated by cyclic GMP-dependent protein kinase during neutrophil spreading. J. Immunol., 166, 5550-5556.
23. LOHMANN S. M., VAANDRAGER A. B., SMOLENSKI A., WALTER U. and DE JONGE H. R. (1997): Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem. Sci., 22, 307-312.
24. MATUSZYK J., KOBZDEJ M., ZIOLO E., KALAS W., KISIELOW P. and STRZADALA L. (1998): Thymic lymphomas are resistant to Nur77-mediated apoptosis. Biochem. Biophys. Res. Comm., 249, 279-282.
25. MIYAKOSHI M., YAMADA T., KATAYAMA H., MURAYAMA T. and NOMURA Y. (1998): Regulation of cyclic GMP and cyclic AMP production by S-nitroso-cysteine in rat thymocytes. Eur. J. Pharmacol., 359, 235-241.
26. O'DORISIO M. S., FERTEL R., FINKLER E., BROOKS R. and VASSALO L. (1984): Characterization of cyclic nueleotide metabolism during human monocyte differentiation. J. Leukoc. Biol., 35, 617-630.
27. PAOLUCCI C., ROVERE P., DE NADAI C., MANFREDI A. A. and CLEMENTI E. (2000): Nitric oxide inhibits the tumor necrosis factor alpha-regulated endocytosis of human dendritic cells in a cyclic GMP-dependent way. J. Biol. Chem., 275, 19638-19644.
28. PRYZWANSKY K. B., KIDAO S., WYATT T. A., REED W. and LINCOLN T. M. (1995): Localization of cyclic GMP-dependent protein kinase in human mononuclear phagocytes. J. Leukoc. Biol., 57, 670-678.
29. SCIORATI C., ROVERE P., FERRARINI M., HELTAI S., MANFREDI A. A. and CLEMENTI E. (1997): Autocrine nitric oxide modulates CD95-induced apoptosis in γδ T lymphocytes. J. Biol. Chem., 272, 23211-23215.
30. SODERLING S. H. and BEAVO J. A. (2000): Regulation of cAMP and cGMP signaling: new phosphodiesterase and new functions. Curr. Opin. Cell Biol., 12, 174-179.
31. STRZADALA L., MIAZEK A., MATUSZYK J. and KISIELOW P. (1997): Role of thymic selection in the development of thymic lymphomas in TCR transgenic mice. Int. Immunol., 9, 127-138.
32. SULTANIAN R., DENG Y. and KAUFMAN S. (2001): Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat. J. Physiol., 533 (Pt I), 273-280.
33. SYROVETS T., TIPPLER B., RIEKS M. and SIMMET T. (1997): Plasmin is a potent and specific chemoattractant for human peripherial monocytes acting via a cyclic guanosine monophosphate-dependent pathway. Blood, 89, 4574-4583.
34. VOLLMAR A. M. and SCHULZ R. (1990): Atrial natriuretic peptide in lymphoid organs of various species. Comp. Biochem. Physiol., 96A, 459-463.
35. WANIKIAT P., WOODWARD D. F. and ARMSTRONG R. A. (1997): Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils. Br. J. Pharmacol., 122, 1135-1145.